"Outside of metastatic castrate-resistant prostate cancer, both NCCN and ASCO do note that an osteoclast inhibitor (at ...

Prostate cancer, a growing concern worldwide, often progresses silently, making early detection crucial. Symptoms like ...

Men on active surveillance for low- to intermediate-risk prostate cancer (PCa) have low risk for PCa-related mortality at a median follow-up of 18 years. However, a majority of men do progress and ...

DynaCAD urology with advanced annotation UroNav cart with advanced annotation option UroNav with advanced annotation July 23, 2025 Supporting prostate cancer diagnosis with more precise guidance for ...

American Idol' host Ryan Seacrest opened up about his father's prostate cancer journey during an emotional broadcast of 'On ...

With an estimated 1.5 million new cases and 397,000 deaths worldwide, prostate cancer is the world's second most frequent ...

Results of a study led by VHIO’s Prostate Cancer Group suggest that treatment with CDK4/6 inhibitors followed by senloytic ...

Ryan Seacrest is getting candid. Seacrest, 50, got emotional and teared up during a July 21 broadcast of “On Air With Ryan ...

Darolutamide receives EU approval in third indication for patients with advanced prostate cancer European Commission granted ...

During Monday's episode of On Air with Ryan Seacrest, Ryan Seacrest opened up about his father, Gary Seacrest's, battle with ...

The monarch, 76, opened up about his health in a conversation with a cancer survivor during a royal engagement Tuesday.

Pharmaceutical scientists, clinicians, nurses and pharmacists from the National University of Singapore (NUS) and National University Hospital (NUH) have shown that a reduced dose of abiraterone ...